| Dr Ernest J Hoefner, DO | |
|
5115 Bernard Drive Suite 201, Roanoke, VA 24018-4327 | |
| (540) 345-0289 | |
| (540) 345-9569 |
| Full Name | Dr Ernest J Hoefner |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 25 Years |
| Location | 5115 Bernard Drive Suite 201, Roanoke, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730178708 | NPI | - | NPPES |
| 15824721 | Medicaid | NM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | A1272-04 (New Mexico) | Secondary |
| 207L00000X | Anesthesiology | 0102205460 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carilion Medical Center | Roanoke, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Acv Inc | 3870633936 | 60 |
News Archive
A new study determines the physical and thermodynamic events associated with the interactions that lead to the fusion between SARS-CoV-2 and the host.
Already in 2014, the German Institute for Quality and Efficiency in Health Care examined in an early benefit assessment whether idelalisib offers advantages over the appropriate comparator therapy for patients with chronic lymphocytic leukaemia (CLL).
Indiana University School of Medicine researchers have identified a mechanism used by the tuberculosis bacterium to evade the body's immune system and have identified a compound that blocks the bacterium's ability to survive in the host, which could lead to new drugs to treat tuberculosis.
The drug acyclovir, which suppresses herpes simplex virus-2, does not reduce the risk of HIV transmission when taken by HIV-positive people who also have herpes, according to a study conducted by researchers at the University of Washington, United Press International reports.
› Verified 6 days ago
| Entity Name | Acv Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881927259 PECOS PAC ID: 3870633936 Enrollment ID: O20091221000602 |
News Archive
A new study determines the physical and thermodynamic events associated with the interactions that lead to the fusion between SARS-CoV-2 and the host.
Already in 2014, the German Institute for Quality and Efficiency in Health Care examined in an early benefit assessment whether idelalisib offers advantages over the appropriate comparator therapy for patients with chronic lymphocytic leukaemia (CLL).
Indiana University School of Medicine researchers have identified a mechanism used by the tuberculosis bacterium to evade the body's immune system and have identified a compound that blocks the bacterium's ability to survive in the host, which could lead to new drugs to treat tuberculosis.
The drug acyclovir, which suppresses herpes simplex virus-2, does not reduce the risk of HIV transmission when taken by HIV-positive people who also have herpes, according to a study conducted by researchers at the University of Washington, United Press International reports.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ernest J Hoefner, DO Po Box 36840, Albuquerque, NM 87176-6840 Ph: (505) 243-7729 | Dr Ernest J Hoefner, DO 5115 Bernard Drive Suite 201, Roanoke, VA 24018-4327 Ph: (540) 345-0289 |
News Archive
A new study determines the physical and thermodynamic events associated with the interactions that lead to the fusion between SARS-CoV-2 and the host.
Already in 2014, the German Institute for Quality and Efficiency in Health Care examined in an early benefit assessment whether idelalisib offers advantages over the appropriate comparator therapy for patients with chronic lymphocytic leukaemia (CLL).
Indiana University School of Medicine researchers have identified a mechanism used by the tuberculosis bacterium to evade the body's immune system and have identified a compound that blocks the bacterium's ability to survive in the host, which could lead to new drugs to treat tuberculosis.
The drug acyclovir, which suppresses herpes simplex virus-2, does not reduce the risk of HIV transmission when taken by HIV-positive people who also have herpes, according to a study conducted by researchers at the University of Washington, United Press International reports.
› Verified 6 days ago
Dr. David S. Hunt, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 5115 Bernard Dr, Suite 201, Roanoke, VA 24018 Phone: 540-345-0289 Fax: 540-345-9569 | |
Dr. Teodulo Remandaban, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 5115 Bernard Dr, Suite 201, Roanoke, VA 24018 Phone: 540-345-0289 Fax: 540-345-9569 | |
Dr. Elizabeth H. Duckworth, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 5115 Bernard Dr, Suite 201, Roanoke, VA 24018 Phone: 540-345-0289 Fax: 540-345-9569 | |
Dr. Charles K. Gadpaille, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 5115 Bernard Dr, Suite 201, Roanoke, VA 24018 Phone: 540-345-0289 Fax: 540-345-9569 | |
Dr. George Landon Smith, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5115 Bernard Dr Ste 201, Roanoke, VA 24018 Phone: 540-345-0289 | |
Dr. Neil A. Macdonald, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5115 Bernard Dr Ste 201, Roanoke, VA 24018 Phone: 540-345-0289 Fax: 540-345-9569 | |
Dr. Patrick Banner Robertson, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5115 Bernard Dr Ste 201, Roanoke, VA 24018 Phone: 540-345-0289 Fax: 540-345-9569 |